DAASO
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Feb 2026)
What this means for you
This application is over — abandoned 16 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98507858
- Mark type
- Stylized text
- Filed
- 18 Apr 2024
- Published for opposition
- 03 Dec 2024
- Abandoned
- 16 Feb 2026
- Attorney of record
- Perry Gattegno
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation
- Class 042 — Scientific and technological services: Biochemical research and development; Biotechnology research; Gene therapy research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research and development in the field of gene therapy, namely, development of oligonucleotides that target more than one aspect of the RNA transcript splicing regulation machinery and process to enhance the potentiation or inhibition of that machinery and process; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- Fosun Pharma USA Inc., Princeton, NJ, US
- Fosun Pharma USA Inc., Princeton, NJ, US
Prosecution history
- 16 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2025 — SOU EXTENSION 1 GRANTED
- 23 Jun 2025 — SOU EXTENSION 1 FILED
- 23 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Nov 2024 — ASSIGNED TO EXAMINER
- 18 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Apr 2024 — NEW APPLICATION ENTERED